As the Food and Drug Administration has approved introduce the Advisa SR MRI SureScan sing-chamber pacemaker in the United States, Medtronic will soon introduce it in the market.
The MRI-conditional device comes with a matching 5076 MRI lead, the combination allowing for magnetic resonance scans on any part of the body, given a few precautions.
The Advisa SR MRI has been updated with additional information management and storage, with a battery life 35 longer than the Adapta pacemaker and compatibility with MR scans.
"MRI is a vital diagnostic tool that was not available to pacemaker patients before Medtronic released the world's first MR-conditional pacing system in 2008," said Brian Urke, Vice president and general manager of the bradycardia business at Medtronic.
Medtronic MR-conditional pacing systems have been evaluated in four clinical studies with more than 3,600 patients and offer the most extensive portfolio of MR-conditional pacing devices.
The Advisa single chamber pacemaker is the latest addition to a growing number of Medtronic devices that are designed for MRI access.